title: [Pharmacological treatment].
abstract: Alzheimer's disease (AD) is a chronic degenerative and inflammatory process leading to synapticdysfunction and neuronal death. A review about the pharmacological treatment alternatives is made: acetylcholinesterase inhibitors (AChEI), a nutritional supplement (Souvenaid) and Ginkgo biloba. A special emphasis on Ginkgo biloba due to the controversy about its use and the approval by the European Medicines Agency is made.
authors.affiliation: Unidad de Memoria y Alzheimer (UMA), Matia Fundazioa, San Sebastián, España. Electronic address: enrique.arriola@matiafundazioa.net.
authors.forename: Enrique
authors.initials: E
authors.lastname: Arriola Manchola
authors.affiliation: Unidad de Memoria y Alzheimer (UMA), Matia Fundazioa, San Sebastián, España.
authors.forename: Javier
authors.initials: J
authors.lastname: Álaba Trueba
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D020441:Ginkgo biloba; D006801:Humans; D010936:Plant Extracts / Q000627:therapeutic use
chemical_list: D002800:Cholinesterase Inhibitors; D010936:Plant Extracts
keywords: Acetylcholinesterase inhibitors; Alzheimer; Ginkgo biloba; Inhibidores de la acetilcolinesterasa; Memantina; Memantine; Souvenaid